{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-064140","form_type":"8-K","ticker":"AHCO","cik":"0001725255","company_name":"AdaptHealth Corp.","filed_at":"2025-06-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.482128+00:00","generated_at":"2026-05-18T13:29:23.576073+00:00","sec_items":["7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"AdaptHealth closes infusion asset sale, reduces debt by $65M, updates FY2025 guidance","bullets":["Closed disposition of certain infusion assets in Wellness at Home segment; assets had ~$52M annual revenue and ~$5M annual Adjusted EBITDA.","Used proceeds for $65M term loan prepayment; cumulative $135M debt reduction (including $70M prepayment in May).","Revised FY2025 guidance: revenue $3,150M-$3,290M; Adjusted EBITDA $662M-$702M; Free Cash Flow $170M-$190M.","Company expects $30M cash taxes on gains from this disposition."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-064140","json":"https://secwatch.observer/filing/0001104659-25-064140.json","markdown":"https://secwatch.observer/filing/0001104659-25-064140.md","text":"https://secwatch.observer/filing/0001104659-25-064140.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1725255/000110465925064140/0001104659-25-064140-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1725255/000110465925064140/tm2519410d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T13:29:23.576073+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}